Details of the Drug | DrugMAP

General Information of Drug (ID: DMFHTG0)

Drug Name

Bone Marrow-Derived Mesenchymal Stem Cells

Synonyms

BM-MSCs

Indication

Disease Entry	ICD 11	Status	REF
Coronavirus Disease 2019 (COVID-19)	1D6Y	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

TTD ID: D00RAM

References

1	ClinicalTrials.gov (NCT04346368) Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19). U.S. National Institutes of Health.